Beam Therapeutics to present sickle cell therapy data at EHA2026

May 12, 2026 9:30 AM

Beam Therapeutics Inc. (NASDAQ: BEAM) announced it will present updated biomarker data from its BEACON Phase 1/2 clinical trial at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found